Literature DB >> 3265788

Effects of Ro 15-4513, fluoxetine and desipramine on the intake of ethanol, water and food by the alcohol-preferring (P) and -nonpreferring (NP) lines of rats.

W J McBride1, J M Murphy, L Lumeng, T K Li.   

Abstract

The effects of the IP administration of RO 15-4513 (1, 2 and 4 mg/kg), fluoxetine (5 and 10 mg/kg) and desipramine (5 and 10 mg/kg) on the intake of 10% ethanol, H2O and food were determined in the selectively bred alcohol-preferring (P) and -nonpreferring (NP) lines of rats with daily access to fluids being limited to single 2-hour sessions. The imidazobenzodiazepine Ro 15-4513 (a partial inverse benzodiazepine agonist) significantly reduced the intake of 10% ethanol by the P rats to 50-60% of control levels in the first 30 minutes without altering food or H2O intake. The attenuating actions of 2 mg/kg Ro 15-4513 on ethanol intake could be completely blocked by the central benzodiazepine receptor antagonist Ro 15-1788 (10 mg/kg). Ro 15-1788, by itself, produced no effects on alcohol and H2O consumption. The 5 mg/kg dose of fluoxetine significantly reduced 10% ethanol intake by the P rats to 20% of control values without altering either H2O or food consumption. The 10 mg/kg dose of fluoxetine further reduced ethanol intake by the P rats, but this dose also reduced daily food intake to approximately 70% of normal. Desipramine at both doses significantly (p less than 0.05) reduced both ethanol and food uptake by the P rats and had a tendency to reduce H2O consumption as well. In general, the three drugs had effects in the NP rats similar to those observed for the P group, although the effects on 10% ethanol intake were difficult to compare because of the low, variable intake of alcohol by the NP group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265788     DOI: 10.1016/0091-3057(88)90137-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  22 in total

Review 1.  An experimental approach to understanding the genetic and neurobiological basis of alcoholism.

Authors:  T K Li; L Lumeng; W J McBride; J M Murphy
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

2.  Complete suppression of craving in alcohol-dependent individuals: is it possible?

Authors:  Falk Kiefer
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

3.  Free-choice responding for ethanol versus water in alcohol preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide.

Authors:  F Weiss; M Mitchiner; F E Bloom; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  A comparison of dehydroepiandrosterone and 7-keto dehydroepiandrosterone with other drugs that modulate ethanol intake in rats responding under a multiple schedule.

Authors:  Russell Joseph Amato; Mary Worrel Hulin; Peter John Winsauer
Journal:  Behav Pharmacol       Date:  2012-06       Impact factor: 2.293

Review 5.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

6.  The benzodiazepine inverse agonist RO19-4603 exerts prolonged and selective suppression of ethanol intake in alcohol-preferring (P) rats.

Authors:  H L June; J M Murphy; J J Mellor-Burke; L Lumeng; T K Li
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

7.  Ethanol self-administration in freely feeding and drinking rats: effects of Ro15-4513 alone, and in combination with Ro15-1788 (flumazenil).

Authors:  H L June; R W Hughes; H L Spurlock; M J Lewis
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

Review 8.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

9.  Negative allosteric modulation of GABAA receptors inhibits facilitation of brain stimulation reward by drugs of abuse in C57BL6/J mice.

Authors:  Matthew E Tracy; Matthew L Banks; Keith L Shelton
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

10.  Blockade of GABA(A) receptors within the extended amygdala attenuates D(2) regulation of alcohol-motivated behaviors in the ventral tegmental area of alcohol-preferring (P) rats.

Authors:  William J A Eiler; Harry L June
Journal:  Neuropharmacology       Date:  2007-03-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.